Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Cognis Meets International Standard for Food Safety
The Cognis esterification plant at the Nutrition & Health Competence Center in Illertissen, Germany, has received the internationally renowned certificate of quality ISO 22000:2005 from the certification body DQS GmbH. The worldwide standard for food safety places rigorous demands on all process levels and along the whole chain of food production – from choosing raw materials and producing ingredients to manufacturing consumer products.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- Workshop Clarifies Health Claims Regulations
Health claims regulation across Asia and the European Union will come under the spotlight at an upcoming workshop hosted by international food and nutrition policy consultancy EAS. ‘The Practical Implications of Claims Regulations and key steps to successfully accessing markets in Asia & Europe’, will guide companies through the current rules for health claims in key Asian markets and Europe. It is scheduled for November 18, 2008.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- The EFSA NDA Panel Shows Promise Amongst Negative Opinions
An article discussing the recent EFSA NDA panel opinions in Europe. With commentary from Cantox's Nigel Baldwin and ESA's Stefanie Geiser.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Food supplement companies looking for strategic solutions for launching food supplements across Europe can find answers at a one-day intensive workshop organised by international food and nutrition policy consultancy EAS.
The workshop, which is being held for the third time this year due to its popularity, is titled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’, and will take place on October 9 in Brussels.
Participants will be taken through a step-by-step process for launching food supplements in the European market – from product entrance strategies to advice on regulations for nutritional and herbal ingredients; information on novel foods procedures and labelling, and the next steps for health claims.
An up-to-date analysis of the most recent regulatory developments in the EU, such as the current climate for herbal ingredients; maximum levels for vitamins and minerals; implications and potential interpretations of the proposed EU Novel Foods Regulation, and health claims will also be presented.
“Navigating the maze of current regulations and making the right strategic judgements in the light of emerging regulatory changes is not easy for companies, particularly at this time”,” said Pieter Lagae, EAS Regulatory Adviser. “This workshop is targeted at guiding companies through the issues and challenges they will meet along the way.”
The workshop will be led by Mr Lagae; EAS Nutritional Product Regulatory Affairs Manager Stefanie Geiser; Katarina Wagner, Regulatory Manager of Nutritional Products; and Scientific and Regulatory Affairs Manager Efi Leontopoulou.
Participants will also benefit from a 45-minute session at the end of the day on the different rules and regulations for accessing the food supplement market in Asia. The session will be presented by Wai Mun Poon, Regional Regulatory Affairs Manager of EAS Asia, which is based in Singapore.
The EAS workshop is limited to 25 participants in order to maximise the value for attendees. For the full workshop programme or to register for the event, visit www.eas.eu or email cindygarcet@eas.eu
|